“Vascular Biology” Featuring Dr. Juan Melero-Martin
“Vascular Biology” Featuring Dr. Juan Melero-Martin
The Stem Cell Podcast—
Gladstone Experts Congenital Heart Disease Cardiovascular Disease Pollard Lab Srivastava LabGladstone NOW: The Campaign Join Us on the Journey ✕
16 - 30 of 113 Results Clear All
The Stem Cell Podcast—
Gladstone Experts Congenital Heart Disease Cardiovascular Disease Pollard Lab Srivastava LabGenetic Engineering & Biotechnology News—Gladstone President Deepak Srivastava explains how his lab’s discovery could pave the way for treatments that prevent heart malformations in people with Down syndrome.
Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava LabAfter decades of mystery, Gladstone researchers identify a gene that can derail heart formation—and show that fixing it prevents the problem in mice.
News Release Research (Publication) Congenital Heart Disease Cardiovascular Disease Pollard Lab Srivastava Lab AI CRISPR/Gene Editing Stem Cells/iPSCsTwo ambitious research projects led by Gladstone investigators are boosted by funds from the California Institute for Regenerative Medicine.
Grants News Release Congenital Heart Disease Cardiovascular Disease Bruneau Lab Conklin Lab CRISPR/Gene Editing Human Genetics Regenerative MedicineLeveraging modern scientific tools and techniques, Jain intends to transform our understanding of the critical roles that vitamins play in health and disease.
Awards News Release Cardiovascular Disease Jain Lab MetabolismBruneau, director of the Gladstone Institute of Cardiovascular Disease, shares exciting recent advances in heart research and talks about the impact of predictive AI.
Gladstone Experts Heart Failure Cardiovascular Disease Alexanian Lab Bruneau Lab Pollard Lab Theodoris Lab AIScience Alert—Gladstone Investigator Isha Jain and her colleagues developed a drug that reduces oxygen delivery from blood to tissues and could help prevent brain damage caused by diseases that cause a toxic oxygen buildup.
Jain Lab Cardiovascular DiseaseNew York Post—Top health researchers from the Murdoch Children’s Research Institute in Australia have teamed with those from Gladstone Institutes in San Francisco on a new program to develop cutting-edge technologies to treat the underlying causes of childhood heart disease more effectively.
Institutional News Cardiovascular DiseaseA new collaboration between Gladstone Institutes and Murdoch Children’s Research Institute to accelerate life-saving therapies for children affected by heart disease.
Institutional News Cardiovascular DiseaseThe new findings have implications for developing immune therapies that target heart disease and chronic conditions in other organs.
News Release Research (Publication) Heart Failure Cardiovascular Disease Alexanian Lab Srivastava LabThe San Francisco Business Times has named Srivastava as one of the Most Admired CEOs among Bay Area businesses and nonprofits. The cardiologist and stem cell pioneer has served in the top leadership role at Gladstone Institutes since 2018.
Awards Institutional News News Release Congenital Heart Disease Cardiovascular Disease Srivastava LabNew York Times—Several new artificial intelligence-powered programs are setting their sights on the fundamentals of biology. They are not simply tidying up the information that biologists are collecting. They are making discoveries about how genes work and how cells develop. Gladstone Assistant Investigator Christina Theodoris shares her journey of creating the deep learning model GeneFormer.
Cardiovascular Disease Theodoris Lab AI Big DataWatch the scientific presentations from the 2024 Bay Area Cardiovascular Science Symposium
Cardiovascular DiseaseAt San Francisco’s Exploratorium, visitors sync their heartbeat with living heart cells; the first-of-its-kind exhibit was created through the museum’s long-running partnership with scientists at Gladstone Institutes.
News Release Stem Cells/iPSCs Conklin Lab Yamanaka Lab Cardiovascular Disease Research (Publication)A new study from Gladstone Institutes sheds light on the molecular workings at play when oxygen exceeds normal levels, with findings that may one day inform the decision to use supplemental oxygen as a medical treatment
News Release Research (Publication) Cardiovascular Disease Jain Lab